Literature DB >> 27904681

MiR-330-3p inhibits gastric cancer progression through targeting MSI1.

Aoran Guan1, Hui Wang2, Xun Li1, Hui Xie1, Ruotian Wang1, Yankun Zhu1, Ruhong Li1.   

Abstract

Increasing evidences demonstrated that microRNAs (miRNAs) play critical roles in the human tumor development and progression. In our study, we found that miR-330-3p expression was downregulated in gastric cancer cell lines and tissues. Ectopic expression of miR-330-3p suppressed the gastric cancer cell proliferation, colony formation and migration. Overexpression of miR-330-3p promoted E-cadherin expression and inhibited the expression of N-cadherin, vimentin and snail. We identified Musashi-1 (MSI1) as a direct target gene of miR-330-3p in gastric cancer cell. In addition, MSI1 was upregulated in gastric cancer cell lines and tissues and the MSI1 expression was inversely correlated with miR-330-3p expression in gastric cancer tissues. MiR-330-3p expression was increased in gastric cancer cells after treated with histone deacetylase inhibitor trichostatin A (TSA) and DNA methylation inhibitor 5-aza-CdR (AZA). These indicated that downregulated expression of miR-330-3p was partly mediated by gene promoter region hypermethylation. These results suggested that miR-330-3p acted as a tumor suppressor gene in GC.

Entities:  

Keywords:  Gastric cancer; Musashi-1 (MSI1); miR-330-3p; miRNAs; microRNAs

Year:  2016        PMID: 27904681      PMCID: PMC5126323     

Source DB:  PubMed          Journal:  Am J Transl Res            Impact factor:   4.060


  53 in total

1.  MicroRNA-650 targets ING4 to promote gastric cancer tumorigenicity.

Authors:  XueLi Zhang; WeiYing Zhu; JiFa Zhang; ShouJun Huo; LianMing Zhou; Zhen Gu; Min Zhang
Journal:  Biochem Biophys Res Commun       Date:  2010-04-08       Impact factor: 3.575

2.  Similarly up-regulated microRNA-106a in matched formalin-fixed paraffin-embedded and fresh frozen samples and the dynamic changes during gastric carcinogenesis and development.

Authors:  Meng Zhu; Ning Zhang; Shuixiang He
Journal:  Pathol Res Pract       Date:  2014-07-30       Impact factor: 3.250

3.  MiRNA-34a inhibits EGFR-signaling-dependent MMP7 activation in gastric cancer.

Authors:  Gang Liu; Chuanshen Jiang; Dazhou Li; Rong Wang; Wen Wang
Journal:  Tumour Biol       Date:  2014-07-01

Review 4.  MicroRNAs predict and modulate responses to chemotherapy in colorectal cancer.

Authors:  Xin Yu; Zheng Li; Jun Yu; Matthew T V Chan; William K K Wu
Journal:  Cell Prolif       Date:  2015-07-22       Impact factor: 6.831

Review 5.  MicroRNA dysregulation in rhabdomyosarcoma: a new player enters the game.

Authors:  Zheng Li; Xin Yu; Jianxiong Shen; Yang Liu; Matthew T V Chan; William K K Wu
Journal:  Cell Prolif       Date:  2015-07-23       Impact factor: 6.831

6.  miR-485-5p acts as a negative regulator in gastric cancer progression by targeting flotillin-1.

Authors:  Min Kang; Mei-Ping Ren; Lei Zhao; Chang-Ping Li; Ming-Ming Deng
Journal:  Am J Transl Res       Date:  2015-11-15       Impact factor: 4.060

7.  miR-761 inhibits tumor progression by targeting MSI1 in ovarian carcinoma.

Authors:  Can Shi; Zhenyu Zhang
Journal:  Tumour Biol       Date:  2015-11-12

8.  The RNA binding protein Musashi1 regulates apoptosis, gene expression and stress granule formation in urothelial carcinoma cells.

Authors:  Parvaneh Nikpour; Modjtaba Emadi Baygi; Christine Steinhoff; Christiane Hader; Anna C Luca; Seyed J Mowla; Wolfgang A Schulz
Journal:  J Cell Mol Med       Date:  2010-05-14       Impact factor: 5.310

9.  Extensive sequence variation in the 3' untranslated region of the KRAS gene in lung and ovarian cancer cases.

Authors:  Minlee Kim; Xiaowei Chen; Lena J Chin; Trupti Paranjape; William C Speed; Kenneth K Kidd; Hongyu Zhao; Joanne B Weidhaas; Frank J Slack
Journal:  Cell Cycle       Date:  2014-02-03       Impact factor: 5.173

10.  Musashi-1 regulates AKT-derived IL-6 autocrinal/paracrinal malignancy and chemoresistance in glioblastoma.

Authors:  Hsiao-Yun Chen; Liang-Ting Lin; Mong-Lien Wang; Shu-Hsien Lee; Ming-Long Tsai; Chi-Chang Tsai; Wei-Hsiu Liu; Tzu-Chien Chen; Yi-Ping Yang; Yi-Yen Lee; Yuh-Lih Chang; Pin-I Huang; Yi-Wei Chen; Wen-Liang Lo; Shih-Hwa Chiou; Ming-Teh Chen
Journal:  Oncotarget       Date:  2016-07-05
View more
  23 in total

1.  SNMFSMMA: using symmetric nonnegative matrix factorization and Kronecker regularized least squares to predict potential small molecule-microRNA association.

Authors:  Yan Zhao; Xing Chen; Jun Yin; Jia Qu
Journal:  RNA Biol       Date:  2019-11-27       Impact factor: 4.652

2.  Circ_0120175 promotes laryngeal squamous cell carcinoma development through up-regulating SLC7A11 by sponging miR-330-3p.

Authors:  Daqing Fan; Youhua Zhu
Journal:  J Mol Histol       Date:  2022-02-10       Impact factor: 2.611

3.  The homeostatic malfunction of a novel feedback pathway formed by lncRNA021545, miR-330-3p and epiregulin contributes in hepatocarcinoma progression via mediating epithelial-mesenchymal transition.

Authors:  Siwen Yang; Yunkun Zhang; Chunmei Guo; Rui Liu; Maroua Elkharti; Zhenhua Ge; Qinlong Liu; Shuqing Liu; Ming-Zhong Sun
Journal:  Am J Cancer Res       Date:  2022-06-15       Impact factor: 5.942

Review 4.  Nerves in gastrointestinal cancer: from mechanism to modulations.

Authors:  Nathalie Vaes; Musa Idris; Werend Boesmans; Maria M Alves; Veerle Melotte
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-09-02       Impact factor: 73.082

5.  Inhibition of Musashi-1 enhances chemotherapeutic sensitivity in gastric cancer patient-derived xenografts.

Authors:  Fan Liu; Huan Yang; Xinyu Zhang; Xianglin Sun; Jiamin Zhou; Yuan Li; Yifei Liu; Zhixiang Zhuang; Guohua Wang
Journal:  Exp Biol Med (Maywood)       Date:  2022-02-08

6.  MiR-330-3p functions as a tumor suppressor that regulates glioma cell proliferation and migration by targeting CELF1.

Authors:  Hongbin Wang; Guijing Liu; Tao Li; Naizhu Wang; Jingkun Wu; Hua Zhi
Journal:  Arch Med Sci       Date:  2020-05-08       Impact factor: 3.318

7.  MicroRNA miR-330-3p suppresses the progression of ovarian cancer by targeting RIPK4.

Authors:  Li Cai; Lu Ye; Xiaoqing Hu; Wenfeng He; Debao Zhuang; Qi Guo; Kuanyong Shu; Youkun Jie
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

8.  The Role of miR-330-3p/PKC-α Signaling Pathway in Low-Dose Endothelial-Monocyte Activating Polypeptide-II Increasing the Permeability of Blood-Tumor Barrier.

Authors:  Jiahui Liu; Libo Liu; Shuo Chao; Yunhui Liu; Xiaobai Liu; Jian Zheng; Jiajia Chen; Wei Gong; Hao Teng; Zhen Li; Ping Wang; Yixue Xue
Journal:  Front Cell Neurosci       Date:  2017-12-19       Impact factor: 5.505

Review 9.  Intracellular functions of RNA-binding protein, Musashi1, in stem and cancer cells.

Authors:  Mahboobeh Forouzanfar; Liana Lachinani; Kianoush Dormiani; Mohammad Hossein Nasr-Esfahani; Ali Osmay Gure; Kamran Ghaedi
Journal:  Stem Cell Res Ther       Date:  2020-05-24       Impact factor: 6.832

Review 10.  Musashi-1-A Stemness RBP for Cancer Therapy?

Authors:  Nadine Bley; Ali Hmedat; Simon Müller; Robin Rolnik; Alexander Rausch; Marcell Lederer; Stefan Hüttelmaier
Journal:  Biology (Basel)       Date:  2021-05-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.